YKL-40 and EGFR is a good biomarker for predicting nodal metastasis in anal carcinoma

Colorectal Disease

Volumn 16, Issue 1, 2014, Pages 69-

  Yang, Y ^a,b   Yang, J J ^a   Tao, H ^a   Jin, W S ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ANUS CARCINOMA; CANCER PATIENT; GENE MUTATION; HUMAN; LETTER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADIPOKINES; ANUS NEOPLASMS; CARCINOMA; HUMANS; LECTINS; LYMPHATIC METASTASIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84890299698     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12357     Document Type: Letter

References (8)

1. Mistrangelo M, Senetta R, Racca P et al. A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact. Colorectal Dis 2013; 15: 1382-91.
2. Wang D, Zhai B, Hu F, Liu C, Zhao J, Xu J. High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer. PLoS ONE 2012; 7: e51127.
3. Stawerski P, Wagrowska-Danilewicz M, Stasikowska-Kanicka O, Danilewicz M. Increased tissue immunoexpression of YKL-40 protein in high grade serous ovarian cancers. Pathol Res Pract 2011; 207: 573-6.
4. Roslind A, Johansen JS, Christensen IJ et al. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int J Cancer 2008; 122: 857-63.
5. Castellano I, Mistrangelo M, Crudo V et al. YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival. Histopathology 2009; 55: 238-40.
6. Paliga A, Onerheim R, Gologan A et al. EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors? Br J Cancer 2012; 107: 1864-8.
7. Van Damme N, Deron P, Van Roy N et al. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC Cancer 2010; 10: 189.
8. Walker F, Abramowitz L, Benabderrahmane D et al. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum Pathol 2009; 40: 1517-27.